Home / Countries / France / HIV medicines

France · availability and reimbursement

HIV medicines in France

Of 37 verified HIV medicine records for France, 35 are available and reimbursed (95%), 0 are available but not reimbursed and 2 are not available. 5 further records are still under review.

95% of verified records reimbursed

Last checked 02/11/2026 · This is information only, not advice or a recommendation.

Medicines by status

Available and reimbursed 35

Apretude, Biktarvy, Celsentri, Delstrigo, Descovy, Dovato, Edurant, Emtriva, Epivir, Eviplera, Generic TDF/FTC (Emtricitabine/Tenofovir DF), Genvoya, Intelence, Isentress, Juluca, Kaletra, Kivexa, Norvir, Odefsey, Pifeltro, Prezista, Rekambys, Retrovir, Reyataz, Rukobia, Stribild, Sunlenca, Symtuza, Tivicay, Triumeq, Truvada, Viread, Vocabria, Vocabria / Rekambys, Ziagen

Not available 2

Generic TLD (Tenofovir/Lamivudine/Dolutegravir), Generic TLE (Tenofovir/Lamivudine/Efavirenz)

Under review 5

Emtricitabine / Rilpivirine / Tenofovir Alafenamide Viatris, Emtricitabine / Tenofovir alafenamide Viatris, Evotaz, Rezolsta, Yeytuo

See every medicine with its source →

More about France

PrEPDoxyPEPSexuality educationAbortion and contraceptionMigrant healthcareFull France profile

Neighbouring countries

SwitzerlandSpainMonacoLuxembourgItalyGermanyBelgiumAndorra

Open the interactive map

Based on public, cited sources and SHAPE's review. Rules and prices change, so please confirm with the national authority or a professional. Found an error? Tell us.